Physician

Alpa Pravinbhai Patel, MD

According to 2025 Medicare claims, Alpa Patel, MD (NPI: 1770512360) practices endocrinology in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is WELLSPAN MEDICAL GROUP (NPI: 1578623781; TIN: 23-2730785) and primary practice location at 17402-4648. Patel is affiliated with the WellSpan Population Health Services (ACO ID: A2500), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 372 traditional Medicare patients, billed 6,221 HCPCS/CPT codes, and received $131,975 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,768 prescription claims across 488 beneficiaries totaling $1,503,235 in drug costs, led by Ozempic (Semaglutide). DME data shows 818 claims. Open Payments data shows 1 records totaling $19. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $704,209 to $1,503,235. For DME billing, reported payments rose steadily, from $11,575 to $255,309.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	539	7,319	$111,314
2016	484	4,844	$103,363
2017	467	5,596	$106,346
2018	407	7,641	$104,227
2019	440	7,901	$139,124
2020	376	6,876	$103,306
2021	349	5,395	$104,785
2022	342	8,341	$102,895
2023	365	4,113	$108,919
2024	372	6,221	$131,975

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	373	2,428	$704,209
2016	407	3,030	$840,521
2017	329	2,456	$545,000
2018	352	2,692	$689,839
2019	445	3,080	$905,273
2020	441	2,988	$1,082,120
2021	401	2,686	$1,040,012
2022	397	2,779	$1,129,319
2023	469	3,475	$1,811,208
2024	488	3,768	$1,503,235

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	125	418	$23,654
2016	176	537	$35,534
2017	98	313	$20,851
2018	120	446	$49,686
2019	220	801	$128,486
2020	205	993	$169,732
2021	177	1,037	$190,847
2022	148	1,001	$190,788
2023	174	1,096	$230,782
2024	181	818	$266,601

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	83	95	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	302	406	$86
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	115	286	$24
J0897	Injection, denosumab, 1 mg	37	3,120	$20
96372	Injection of drug or substance under skin or into muscle	42	76	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	281	13,161	$406,815
Trulicity	Dulaglutide	126	5,236	$170,263
Jardiance	Empagliflozin	150	9,152	$170,227
Novolog Flexpen	Insulin Aspart	193	11,077	$74,217
Mounjaro	Tirzepatide	54	1,850	$66,397

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	117	579	$214,254
E0784	External ambulatory infusion pump, insulin	Y	N/R	65	$21,206
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	16	50	$12,026
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	14	43	$11,391
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	16	49	$3,986

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$19	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alpa Pravinbhai Patel, MD?

Tedicare shows public-source Medicare data for Alpa Pravinbhai Patel, MD (NPI 1770512360), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alpa Pravinbhai Patel, MD have ACO affiliation data?

Alpa Pravinbhai Patel, MD is shown with ACO affiliation data for WellSpan Population Health Services (MSSP, ACO ID A2500).

What billing organization is linked to Alpa Pravinbhai Patel, MD?

Alpa Pravinbhai Patel, MD is linked to WELLSPAN MEDICAL GROUP (billing NPI 1578623781) in the available physician profile data.

Does Alpa Pravinbhai Patel, MD have Open Payments data?

Alpa Pravinbhai Patel, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.